Haas M, Dunham P B, Forbush B
Department of Pathology, University of Chicago, Illinois 60637.
Am J Physiol. 1991 Apr;260(4 Pt 1):C791-804. doi: 10.1152/ajpcell.1991.260.4.C791.
Crude plasma membranes from whole mouse kidneys have two classes of [3H]bumetanide binding sites. High-affinity sites (K1/2 approximately equal to 0.04 microM; Bmax = 1-2 pmol/mg protein) are similar to those identified on dog kidney membranes (B. Forbush and H.C. Palfrey. J. Biol. Chem. 258: 11787-11792, 1983) both with respect to affinity and in that Na, K, and Cl are required for [3H]bumetanide binding. Low-affinity sites (K1/2 approximately equal to 1 microM; Bmax = 7-14 pmol/mg) are unaffected by removal of these ions; such sites are not seen with dog kidney. When mouse kidney membranes are photolabeled with 4-[3H]benzoyl-5-sulfamoyl-3-(3-thenyloxy)benzoic acid [( 3H]BSTBA), a photoreactive bumetanide analogue, specific incorporation of the label is seen in two regions. As with dog kidney [M. Haas and B. Forbush. Am. J. Physiol. 253 (Cell Physiol. 22): C243-C252, 1987], an approximately 150-kDa protein is labeled with high affinity (K1/2 approximately equal to 0.05 microM). This labeling also requires Na, K, and Cl and appears to correspond to the high-affinity [3H]bumetanide binding sites and to the Na-K-Cl cotransport system. A second peak of [3H]BSTBA photolabeling, centered at approximately 75 kDa, incorporates the label with lower affinity (K1/2 = 2-3 microM). The photolabeling at approximately 75 kDa is unaffected by Na, K, and Cl concentrations and thus may correspond, at least in part, to the low-affinity [3H]bumetanide binding sites. Western blot analysis of [3H]BSTBA-labeled mouse kidney membranes was performed using an antiserum raised to proteins of approximately 82 and approximately 39 kDa isolated from mouse Ehrlich ascites tumor cells using a bumetanide affinity gel (P. B. Dunham, F. Jessen, and E. K. Hoffmann. Proc. Natl. Acad. Sci. USA 87: 6828-6832, 1990). This antiserum cross-reacts with a approximately 150-kDa mouse kidney protein, the staining profile of which on Western blot corresponds very closely to the peak of specific [3H]BSTBA incorporation in this region. The antiserum also reacts with proteins in the range of 65-85 kDa, overlapping the low-affinity peak of [3H]BSTBA incorporation.
来自整个小鼠肾脏的粗制质膜有两类[³H]布美他尼结合位点。高亲和力位点(K₁/₂约等于0.04微摩尔;Bmax = 1 - 2皮摩尔/毫克蛋白质)在亲和力方面以及在[³H]布美他尼结合需要钠、钾和氯这一点上,与在犬肾膜上鉴定出的位点相似(B. 福布斯和H.C. 帕尔弗里。《生物化学杂志》258: 11787 - 11792, 1983)。低亲和力位点(K₁/₂约等于1微摩尔;Bmax = 7 - 14皮摩尔/毫克)不受这些离子去除的影响;犬肾中未见到此类位点。当用4 - [³H]苯甲酰基 - 5 - 氨磺酰基 - 3 - (3 - 噻嗯氧基)苯甲酸[(³H)BSTBA],一种光反应性布美他尼类似物对小鼠肾膜进行光标记时,在两个区域可见标记的特异性掺入。与犬肾一样[M. 哈斯和B. 福布斯。《美国生理学杂志》253(细胞生理学22): C243 - C252, 1987],一种约150 kDa的蛋白质被高亲和力标记(K₁/₂约等于0.05微摩尔)。这种标记也需要钠、钾和氯,并且似乎对应于高亲和力[³H]布美他尼结合位点以及钠 - 钾 - 氯协同转运系统。[³H]BSTBA光标记的第二个峰,以约75 kDa为中心,以较低亲和力(K₁/₂ = 2 - 3微摩尔)掺入标记。约75 kDa处的光标记不受钠、钾和氯浓度的影响,因此可能至少部分对应于低亲和力[³H]布美他尼结合位点。使用用布美他尼亲和凝胶从小鼠艾氏腹水瘤细胞中分离出的约82 kDa和约39 kDa蛋白质产生的抗血清,对[³H]BSTBA标记的小鼠肾膜进行蛋白质印迹分析(P.B. 邓纳姆、F. 杰森和E.K. 霍夫曼。《美国国家科学院院刊》87: 6828 - 6832, 1990)。这种抗血清与一种约150 kDa的小鼠肾蛋白质发生交叉反应,其在蛋白质印迹上的染色图谱与该区域特异性[³H]BSTBA掺入峰非常紧密地对应。该抗血清还与65 - 85 kDa范围内的蛋白质发生反应,与[³H]BSTBA掺入的低亲和力峰重叠。